Yu-Mi Shim

Yu-Mi Shim

Auto-generated profile, based on publicly available information

Yu-Mi Shim

Department of Pathology, Seoul National University Hospital, College of Medicine, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2021 in Laboratory Investigation
Verified
Journal Article
Open access
HKHyunhee Kim
Hyunhee Kim
KLKa Young Lim
Ka Young Lim
JPJin Woo Park
Jin Woo Park
JKJeongwan Kang
Jeongwan Kang
JWJae Kyung Won
Jae Kyung Won
Sung-Hye ParkSung-Hye Park
Sung-Hye Park
Mismatch repair-deficient (MMRD) brain tumors are rare among primary brain tumors and can be induced by germline or sporadic mutations. Here, we report 13 MMRD-associated (9 sporadic and 4 Lynch syndrome) primary brain tumors to determine clinicopathological and molecular characteristics and biological behavior. Our 13 MMRD brain tumors included glioblastoma (GBM) IDH-wildtype (n = 9) including 1 gliosarcoma, astrocytoma IDH-mutant WHO grade 4 (n = 2), diffuse midline glioma (DMG) H3 K27M-mutant (n = 1), and pleomorphic xanthoastrocytoma (PXA) (n = 1). Next-generation sequencing using a brain tumor-targeted gene panel, microsatellite instability (MSI) testing, Sanger sequencing for germline MMR gene mutation, immunohistochemistry of MMR proteins, and clinicopathological and survival analysis were performed. There were many accompanying mutations, suggesting a high tumor mutational burden (TMB) in 77%, but TMB was absent in one case of GBM, IDH-wildtype, DMG, and PXA, respectively. MSH2, MLH1, MSH6, and PMS2 mutations were found in 31%, 31%, 31% and 7% of patients, respectively. MSI-high and MSI-low were found in 50% and 8% of these gliomas, respectively and 34% was MSI-stable. All Lynch syndrome-associated GBMs had MSI-high. In addition, 77% (10/13) had histopathologically multinucleated giant cells. The progression-free survival tended to be poorer than the patients with no MMRD gliomas, but the number and follow-up duration of our patients were insufficient to get statistical significance. In the present study, we found that the most common MMRD primary brain tumor was GBM IDH-wildtype. The genetic profile of MMRD GBM was different from that of conventional GBM. MMRD gliomas with TMB and MSI-H may be sensitive to immunotherapy but resistant to temozolomide. Our findings can help develop better treatment options.

1 January 2015 in Analytica Chimica Acta
Verified
Journal Article
Closed access
YSYumi Shim
Yumi Shim
MNMyung-Hyun Nam
Myung-Hyun Nam
SHSong Woo Hyuk
Song Woo Hyuk
SYSoo Young Yoon
Soo Young Yoon
Joon Myong SongJoon Myong Song
Joon Myong Song

2 January 2023 in Journal of Neuropathology & Experimental Neurology
Verified
Journal Article
Open access
PDF file
YSYe Yoon Suh
Ye Yoon Suh
KLKwanghoon Lee
Kwanghoon Lee
YSYu-Mi Shim
Yu-Mi Shim
JPJi Hoon Phi
Ji Hoon Phi
CPChul-kee Park
Chul-kee Park
Sung-Hye ParkSung-Hye Park
Sung-Hye Park
The MYB/MYBL1::QKI fusion induces the protooncogene, MYB, and deletes the tumor suppressor gene, QKI. MYB/MYBL1::QKI rearrangement was previously reported only in angiocentric glioma (AG) and diffuse low-grade glioma. This report compares 2 tumors containing the MYB/MYBL1::QKI fusion: a diffuse pediatric-type high-grade glioma (DPedHGG) in an 11-year-old boy and an AG in a 46-year-old woman. We used immunohistochemistry, next-generation sequencing, and methylation profiling to characterize each tumor and compare our findings to the literature on AG and tumors with the MYB/MYBL1::QKI rearrangement. Both tumors were astrocytic with angiocentric patterns. The MYB::QKI fusion-positive DPedHGG, which recurred once, was accompanied by TP53 mutation and amplification of CDK6 and KRAS, suggesting malignant transformation secondary to additional genetic aberrations. The second case was the adult AG with MYBL1::QKI fusion, which mimicked ependymoma based on histopathology and its dot- and ring-like epithelial membrane antigen positivity. Combined with a literature review, our results suggest that MYB/MYBL1 alterations are not limited to low-grade gliomas, including AG. AG is most common in the cerebra of children and adolescents but exceptional cases occur in adults and the acquisition of additional genetic mutations may contribute to high-grade glioma. These cases further demonstrate that molecular characteristics, morphologic features, and clinical context are essential for diagnosis.

28 July 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
SYSooyeon Yoo
Sooyeon Yoo
KLKwanghoon Lee
Kwanghoon Lee
JSJunseo Seo
Junseo Seo
HCHwisoo Choi
Hwisoo Choi
SKSeong-Ik Kim
Seong-Ik Kim
Sung-Hye ParkSung-Hye Park
Sung-Hye Park
The heterogeneity of Parkinson’s disease (PD) is increasingly recognized as an important aspect of understanding the disorder. Among the factors contributing to this heterogeneity, ethnic differences are primary sources, significantly influencing the likelihood of PD developing and its initial symptoms’ nature. While there have been numerous reports related to PD in East Asia, there has been a lack of contribution from single-cell (or nucleus) transcriptome studies, which have been making significant contributions to understanding PD. In this study, a total of 33,293 nuclei obtained from the substantia nigra (SN) of confirmed pathological PD and control patients in South Korea were profiled, revealing 8 different cell types through cluster analysis. Monocle-based pseudotime analysis identified two disease-associated trajectories for each astrocyte and microglia and identified genes that differentiate them. Interestingly, we uncovered the inflammatory intervention in the early PD-associated transition in microglia and identified the molecular features of this intermediate state of microglia. In addition, gene regulatory networks (GRNs) based on TENET analysis revealed the detrimental effect of an HSPA5- led module in microglia and MSRB3- and HDAC8- led modules specifying the two different astrocyte trajectories. In SN neurons, we observed population changes, a decrease in dopaminergic and glutamatergic neurons and a proportional increase in GABAergic neurons. By deconvolution in spatial transcriptome obtained the PD sample, we confirmed spatiotemporal heterogeneity of neuronal subpopulations and PD-associated progressive gliosis specific to dopaminergic nuclei, SN and ventral tegmental areas (VTAs). In conclusion, our approach has enabled us to identify the genetic and spatial characterization of neurons and to demonstrate different glial fates in PD. These findings advance our molecular understanding of cell type-specific changes in the progression of Korean PD, providing an important foundation for predicting and validating interventions or drug effects for future treatments.

26 October 2026 in Signal Transduction and Targeted Therapy
Verified
Journal Article
Open access
PDF file
SYSooyeon Yoo
Sooyeon Yoo
KLKwanghoon Lee
Kwanghoon Lee
JSJunseo Seo
Junseo Seo
HCHwisoo Choi
Hwisoo Choi
SKSeong-Ik Kim
Seong-Ik Kim
Sung-Hye ParkSung-Hye Park
Sung-Hye Park
Parkinson’s disease (PD) is clinically and biologically heterogeneous, and ethnic differences may influence its pathogenesis. However, single-nucleus transcriptomic data from East Asian populations remain limited. Here, we present a spatially resolved single-nucleus transcriptomic atlas of the human substantia nigra (SN) across the PD continuum, control, incidental Lewy body disease (iLBD), and advanced PD, in pathologically confirmed Korean individuals. Our integrative analysis revealed early α-synuclein aggregation in the ventrolateral SN, subtype-selective vulnerability of dopaminergic neurons, and relative preservation of the dorsomedial SN and ventral tegmental area. Trajectory and gene regulatory network analyses of astrocytes and microglia revealed spatiotemporally distinct, disease-associated glial responses, each driven by divergent molecular programs. We also identified two transcriptionally distinct vascular spatial clusters that exhibited differential vulnerability and remodeling. Spatial ligand–receptor analysis of α-synuclein-positive regions revealed intercellular signaling events associated with early pathology, including extracellular matrix remodeling and synaptic adhesion, which were prominent in the iLBD but largely diminished in advanced PD. Integration with PD genome-wide association studies using MAGMA demonstrated differential coupling between genetic risk, spatially resolved cell-state programs, and pseudotime-inferred microglial dynamics across ancestries. This study provides the first high-resolution, spatially mapped single-nucleus transcriptomic resource from an East Asian PD cohort, illuminating early perturbations in the midbrain intercellular and microenvironment that may underlie selective dopaminergic vulnerability and guide the development of ancestry-informed therapeutic strategies.